Table 4

Relative exposure values for metabolites in plasma following a single oral or intravenous dose of [¹⁴C]nateglinide

Metabolite^4-a	Oral 120-mg, AUC_0–12h	Intravenous 60-mg, AUC_0–4h
	ngEq · h/ml
M11	442	123
M12	330	102
M1	1100	433
M2, M3	436	162
M7	516	203

↵4-a Chemical structures are shown in Fig. 1.